Mother-Infant Dyad & Integrated Perinatal SUD Care

Drug overdose is a leading cause of pregnancy-related death in the United States, with over 1,249 pregnancy-associated overdose deaths between 2017 and 2020. Integrated care models that co-locate obstetric, addiction, mental health, and social services produce the strongest outcomes.

69% buprenorphine continuation at 6 months postpartum in integrated OB/Addiction clinics
Substantially improved screening rates and safe plans of care in statewide quality collaboratives
Eat, Sleep, Console (ESC) approach reduces NOWS pharmacotherapy by 63%
The postpartum period (7-12 months) represents peak overdose risk window

This guide synthesizes evidence into a comprehensive framework for perinatal SUD consultation, defining the minimum effective dyad-care package and comparing four evidence-based care delivery models. It addresses implementation science through AIM bundle adaptation and presents longitudinal cases anchoring ethical reasoning.

Clinical Problem

Pregnant and parenting women with substance use disorder (SUD) face unique risks, and outcomes improve significantly when care is integrated for both mother and infant. Traditional siloed care often fails these families:

Women with SUD may avoid prenatal care out of fear of punitive action (e.g., child welfare involvement)
Standard prenatal/postpartum care may miss critical behavioral health and social needs
Fragmented systems lead to communication failures between obstetric, addiction, and pediatric providers

Critical Data: Integrated obstetric–addiction programs cut preterm birth rates by more than half (11.8% vs 26.6%) and shortened infant hospital stays significantly.

Core Principles

The Dyad-Care Package (Minimum Effective Standards)

An effective dyad-centered care package includes evidence-based interventions addressing both maternal SUD treatment and infant well-being:

1. Universal Screening & Early Identification

Routine, validated screening for substance use in all pregnant patients
Screen at first prenatal visit and periodically in pregnancy and postpartum
Screen for mental health conditions (depression, trauma) and social needs

2. MOUD Continuity Plan

Initiate MOUD (buprenorphine or methadone) as early as possible
Continue through delivery and beyond
MOUD is gold standard—withdrawal/detox associated with 59-90% relapse rates
Coordinated pain management plan for labor and delivery

3. Neonatal Monitoring (NOWS/NAS)

Ensure delivering hospital is prepared with standardized assessment tools
Promote rooming-in and breastfeeding when safe
Use Eat, Sleep, Console (ESC) approach

4. Postpartum Mental Health & Relapse Prevention

Routine postpartum depression screening at 4-6 weeks and 3-6 months
Continue SUD counseling into postpartum period
Overdose prevention education and naloxone distribution

5. Family Care Plan & Social Support

Plan of Safe Care for every mother-infant pair affected by SUD
Linkage to pediatric medical home, early intervention services
Recovery support (peer specialists, parenting peer groups)

Screening and Assessment Standards

The AIM bundle mandates screening all pregnant and postpartum people using validated, self-reported tools.

Tool	Purpose	Timing
4P's Plus / 5P's	Alcohol, tobacco, marijuana, illicit drugs + IPV/depression	First visit, each trimester
NIDA Quick Screen / NIDA-Modified ASSIST	Substance use severity	First visit
AUDIT / AUDIT-C	Alcohol use disorders	First visit
EPDS (Edinburgh)	Perinatal depression	Each trimester + 3, 6, 12 weeks PP
PHQ-9 / GAD-7	Depression and anxiety	Each trimester + postpartum
PC-PTSD-5	Trauma history	First visit

          Key Point: Toxicology with informed maternal consent—biological testing should not replace verbal screening and requires explicit consent.
        

MOUD Continuity and Pain Management

Phase	Key Actions
Prenatal	Initiate MOUD as early as possible; earlier initiation predicts postpartum continuation. Dose adjustments in 3rd trimester (increased metabolism); consider split dosing for methadone.
Intrapartum	Continue baseline MOUD dose—does NOT provide adequate analgesia. Avoid partial agonist-antagonists (butorphanol, nalbuphine, pentazocine).
Postpartum	Reassess dose (metabolism normalizes; may need adjustment). Plan for 12-month MOUD continuation minimum.

Peripartum Pain Management Protocol (Multimodal)

Continue baseline MOUD
Regional analgesia first-line (epidural/spinal)
Non-opioid adjuvants (acetaminophen, NSAIDs postpartum, gabapentin)
Short-acting opioids PRN (30-50% higher doses due to tolerance)
Anesthesia consultation prenatally in 3rd trimester
Limit opioid discharge prescriptions (3-7 days maximum)

Neonatal Monitoring Coordination (NOWS/NAS)

Eat, Sleep, Console (ESC) Evidence: Infants cared for with ESC were medically ready for discharge 6.7 days earlier and 63% less likely to receive pharmacotherapy compared to Finnegan scoring.

Neonatal Monitoring Checklist

Monitoring duration: Minimum 4-7 days post-birth; longer for methadone exposure
Rooming-in: Dyad remains together; avoid routine NICU admission
Breastfeeding: Strongly recommended if mother is stable on MOUD
Pharmacologic treatment if needed: Oral morphine or methadone first-line
Prenatal NOWS education: Provide anticipatory guidance in 3rd trimester

Models of Integrated Care

Domain	Integrated OB–SUD Clinics	Residential Programs	Postpartum Transition	Home-Visiting/Peer
Setting	Co-located outpatient	Live-in with children	4th trimester focus	Community-based
MOUD Retention	69% at 6 months	High during treatment	Prevents postpartum gaps	Facilitates linkage
Strengths	One-stop care; reduces barriers	Addresses housing/safety	Targets highest-risk period	Cultural competency; trust
Ideal for	Stable housing patients	Unstable housing; CPS involved	All patients during transition	Underserved populations

      Synthesis: No single model is sufficient alone. The strongest evidence supports layered, step-wise care—integrated OB-SUD clinics as the medical home, supplemented by residential options when indicated, robust postpartum transition planning, and community-based peer supports.
    

Implementation and Patient Safety

AIM Bundle Adaptation (5 R's Framework)

READINESS

Train staff in trauma-informed care, naloxone distribution, develop protocols

RECOGNITION

Universal SBIRT at first prenatal visit and each trimester

RESPONSE

Warm handoff to MOUD within 72 hours; mental health co-visit; POSC initiation

REPORTING

Standardized documentation; quality metrics dashboard

RESPECTFUL CARE

Patient advisory boards; person-first language; shared decision-making

Ethics and Legal Considerations

Non-Punitive Documentation & Language

Document factually using person-first language
Avoid judgmental terms ("addict," "dirty urine")
Include patient's progress and strengths
Document consent for sensitive actions

Consent for Substance Testing

Supreme Court Ruling (2001): Hospitals cannot perform drug tests on pregnant patients for the purpose of reporting to law enforcement without consent.

Preferred approach: Universal verbal screening
Biologic testing only with informed consent
Discuss any potential implications including reporting rules
Keep results confidential to care team

Perinatal SUD Consultation Algorithm

Outpatient Algorithm (Prenatal Through Postpartum)

First Prenatal Visit

Screen Negative
→ Rescreen each trimester

Screen Positive
→ Brief Intervention + Assessment

Meets Criteria for OUD/SUD?

Motivational Interview
+ Harm Reduction Education

Warm Handoff to Integrated OB/Addiction Team
→ Same-day or ≤72hr MOUD induction

Ongoing Management

Monthly visits, MOUD optimization, mental health assessment, POSC development

Delivery Hospitalization

Continue MOUD, multimodal pain, ESC monitoring, warm handoff at discharge

Postpartum Transition (0-12 months)

Weekly to monthly touchpoints, MOUD continuation ≥12 months, pediatric coordination

Quick Reference Tables

Teaching Points Summary

Screen universally — validated self-report tools at every entry point
Initiate MOUD early and maintain continuously — through pregnancy, delivery, and minimum 12 months postpartum
Coordinate peripartum pain — multimodal protocol; continue MOUD
Monitor neonates with ESC — rooming-in, breastfeeding support
Integrate postpartum mental health — depression/PTSD screening and treatment
Complete Plans of Safe Care collaboratively — patient as full partner
Execute warm handoffs at every transition
Layer supports — peer specialists, doulas, home visiting
Practice harm reduction — no discharge for relapse
Address bias systematically — standardized protocols reduce disparities

Key National Frameworks

Framework	Issuing Body	Key Contribution
SAMHSA Clinical Guidance	SAMHSA/HHS	16 factsheets covering prenatal through infant care
AIM CPPPSUD Bundle	ACOG/HRSA	5 Rs framework for implementation
ESC-NOW Trial	NIH/NICHD	RCT evidence for Eat, Sleep, Console
CAPTA / Plans of Safe Care	HHS/ACF	Federal requirements for notification and support